News
Neuroendocrine Differentiation and Enzalutamide Resistance in Prostate Cancer
In a recent highlight of DOD-funded projects, we learn of Isaac Y. Kim, MD, PhD, MBA, and his team's discovery surrounding a possible connection between neuroendocrine differentiation and androgen signaling. Further development of the study could benefit those with castrate-resistant prostate cancer.
Source: Department of Defense [DOD] - Congressionally Directed Medical Research Program Highlights